Shin Nippon Biomedical Laboratories, Ltd. - Insider Non-Derivative Transactions at Satsuma Pharmaceuticals, Inc. (STSA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 8, 2023, Shin Nippon Biomedical Laboratories, Ltd.'s relationship to Satsuma Pharmaceuticals, Inc. (STSA) is TenPercentOwner, and currently has 8,423,732 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other STSA insiders.
Data Source: SEC.
Shin Nippon Biomedical Laboratories, Ltd. - Insider Non-Derivative Transactions of STSA Common Stock
Shin Nippon Biomedical Laboratories, Ltd. - Insider Non-Derivative Transactions at STSA
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 9, 2023 | P -- (Common Stock) | 8423732 | 0.91 | 8423732 |
| Jun 7, 2023 | P -- (Common Stock) | 22053581 | 0.91 | 22053581 |